Health TrialsbyHealthPanel

Does Virtual Reality Improve Symptom Burden in Dialysis Patients?

ConditionsDialysisVirtual Reality
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDavid Blum

About this trial

The goal of this clinical trial is to investigate the use of virtual reality therapy in dialysis patients. The main question it aims to answer is: Does virtual reality improve symptom burden in dialysis patients and improve their mental wellbeing? Over a period of one month, one virtual reality therapy session of 30 minutes will be performed during each regular hemodialysis session. Since we will conduct a monocentric, crossover randomized controlled trial, the participants act as their own control group.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Older than 18 years;

in treatment with thrice-weekly hemodialysis sessions;

regular hemodialysis duration of three to five hours

having no visual impairment

Disqualifiers

diagnosis of epilepsy

current pregnancy

Trial design

Design model

Crossover

Treatments tested in this trial

  • virtual reality therapy

    Other intervention

    A virtual reality therapy will be applied for 30 minutes. Patients will be wearing the glasses while lying in bed/chair during their regular dialysis session. Vital signs will be monitored repeatedly. At defined times, patients are asked to answer various questionnaires about their physical and mental health.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: virtual reality therapy, then standard of careExperimental treatment 1 intervention
Group B: standard of care, then virtual reality therapyExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Reduction of symptom burden of dialysis patients and improvement of their mental wellbeing

questionnaire

Time frame
10 weeks

Secondary outcomes

1

Evaluation of the effects of virtual reality therapy during hemodialysis on heart rate

Heart rate (beats per minute)

Time frame
10 weeks
2

Evaluation of the effects of virtual reality therapy during hemodialysis on blood pressure

Blood pressure (mm Hg)

Time frame
10 weeks
3

To assess the acceptability and appropriateness of using VRT during hemodialysis from the perspectives of patients

questionnaire

Time frame
10 weeks
4

To assess the acceptability and appropriateness of using VRT during hemodialysis from the perspectives of clinical staff

questionnaire

Time frame
10 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

David Blum

Lead sponsor

University of Zurich

Sponsor institution

Source ClinicalTrials.gov
Apply now